Artemisinins inhibit ovarian androgen synthesis and relieve PCOS. Credit: Science (2024). DOI: 10.1126/science.adk5382 A team of metabolic specialists and molecular biologists at Fudan University’s Zhongshan Hospital, working with colleagues from other institutions in China, has found that some antimalarial drugs show promise in treating polycystic ovarian syndrome (PCOS) in women. In their study, published in the journal Science, they tested the drug dihydroartemisinin (a type of artemisinin) in mice and then in a small group of women with PCOS. Elisabet Stener-Victorin, with the Karolinska Institutet, has published a Perspective piece Read More